KD-64 – a new selective A 2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist – caffeine does not reduce diet-induced obesity in mice
Authors:
- Magdalena KotańskaMKMagdalena Kotańska
- Anna DziubinaADAnna Dziubina
- Małgorzata SzafarzMSMałgorzata Szafarz
- Kamil MikaKMKamil Mika
- Karolina RegułaKRKarolina Reguła
- Marek BednarskiMBMarek Bednarski
- Małgorzata ZygmuntMZMałgorzata Zygmunt
- Anna DrabczyńskaADAnna Drabczyńska
- Jacek SapaJSJacek Sapa
- Katarzyna Kieć-KononowiczKKKatarzyna Kieć-Kononowicz
Preprint
Abstract
The A 2 adenosine receptors play an important role, among others, in the regulation of inflammatory process and glucose homeostasis in diabetes and obesity. Thus, the presented project evaluated of influence of the selective antagonist of A 2A adenosine receptor – KD-64 as compared to the known non-selective antagonist – caffeine on these two particular processes. Two different inflammation models were induced namely local and systemic inflammation. Obesity was induced in mice by high-fat diet and the tested compounds (KD-64 and caffeine) were administrated for 21 days. KD-64 showed anti-inflammatory effect in both tested inflammation models and administered at the same dose as ketoprofen exerted stronger effect than this reference compound. Elevated levels of IL-6 and TNF-α observed in obese control mice were significantly lowered by the administration of KD-64 and were similar to the values observed in control non-obese mice. Interestingly, caffeine increased the levels of these parameters. In contrast to caffeine which had no influence on AlaT activity, KD-64 administration significantly lowered AlaT activity in the obese mice. Although, contrary to caffeine, KD-64 did not reduce diet-induced obesity in mice, it improved glucose tolerance. Thus, the activity of the selective adenosine A 2A receptor antagonist was quite different from that of the non-selective.Keywords
All Related Versions
- Published version: PLOS ONE, 15 (6), e0229806.
This publication has 73 references indexed in Scilit:
- Alterations in cardiac DNA methylation in human dilated cardiomyopathyEMBO Molecular Medicine, 2013
- Inflammation, Oxidative Stress, and ObesityInternational Journal of Molecular Sciences, 2011
- Adipokines in inflammation and metabolic diseaseNature Reviews Immunology, 2011
- Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activationRespiratory Research, 2009
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- Systemic administration of the adenosine A2A agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intakePharmacology Biochemistry and Behavior, 2008
- A2A receptors in inflammation and injury: lessons learned from transgenic animalsJournal of Leukocyte Biology, 2007
- Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Dopaminergic Agonists Normalize Elevated Hypothalamic Neuropeptide Y and Corticotropin-Releasing Hormone, Body Weight Gain, and Hyperglycemia in ob/ob MiceNeuroendocrinology, 2000
- Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) miceLife Sciences, 1997